A healthcare AI assistant has more access than it needs when its permissions exceed the records, actions, destinations or duration required for its authorised task. The answer depends on the deployment, not the product's branding. A useful review asks what a mistake could affect and which controls prevent the system from moving beyond its agreed role.
Begin with one job, not an organisation-wide connection
"Connect the assistant to the clinical system" is an incomplete specification. A tool preparing a draft appointment letter needs different access from a service supporting clinical review across an allocated caseload. Neither task automatically justifies unrestricted access to every record and action available to the organisation.
Write the intended job in ordinary language before discussing permissions. Specify who initiates it, which patient or group it concerns, what information is necessary and what counts as completion. Then map each permission to that job. A permission with no clear purpose should become a question for review rather than an unnoticed default.
The NIST zero-trust architecture publication, published in August 2020, rejects implicit trust based simply on network location or ownership. Its relevance here is the focus on authorising access to resources, not assuming that being inside a trusted environment makes every action appropriate.
Read access can already be consequential
A permissions review should not focus only on writing. Reading unnecessary records can expose information that the task did not require. The information may also influence a generated summary or recommendation in ways the user did not intend.
Consider a fictional assistant asked to prepare information for a scheduled encounter. Access might be restricted to the relevant patient context and specified information sources. If the same account can search the entire organisation without a task-specific check, the consequence of a mistaken identity or inappropriate query becomes larger.
This is not an argument that every clinical task should receive a tiny, fragmented history. Too little context can also be unsafe. The proposed balance is sufficient information for the actual purpose, with a deliberate process for requesting more when it is needed.
Separate reading, drafting, committing and closing
These actions deserve distinct permission decisions. Drafting a message does not imply permission to send it. Preparing an order does not imply authority to issue it. Sending information does not establish that the receiving service has accepted responsibility. Marking a workflow complete can itself be consequential if it removes the task from a review queue.
A proposed permission schedule could distinguish the following:
| Capability | Question for the deployment team |
|---|---|
| Read selected information | Which patient, sources and time window are necessary? |
| Prepare a draft | Where is it stored, and who can review it? |
| Commit an external action | What authorisation and destination checks are required? |
| Change completion status | What independent evidence demonstrates completion? |
The table is a review aid, not a regulatory classification. Its value is making permissions that often travel together visible as separate choices.
Scope permissions by patient, destination and time
A user may be entitled to perform a task while the agent still needs a narrower grant for a particular execution. Ask whether authority is bound to the current patient, the intended recipient and the action being approved. A broad account-level permission may not provide that precision by itself.
Time also matters. An assistant that completed a bounded task need not retain an open-ended ability to continue acting. For recurring workflows, review the circumstances that should invalidate the original authorisation: a changed plan, a different responsible team, a withdrawn request or a material product change.
These are proposed controls for assessment, not a claim that every platform currently implements them. Buyers should request demonstrations using the actual configuration rather than infer behaviour from a general security statement.
Approval should reveal what authority is being exercised
A confirmation screen saying "Approve" tells the reviewer little unless the action is visible. The reviewer should be able to identify the patient, the intended change, the destination and the remaining uncertainty. For consequential actions, a summary of the reasoning cannot replace inspection of the material information on which the action depends.
The permission layer also needs to reject actions the user is not entitled to authorise. A model should not be able to persuade its way around that layer by generating a convincing explanation. The NCSC's prompt-injection discussion, published in December 2025, supports limiting the consequences of untrusted content reaching an AI system rather than relying entirely on instructions to the model.
A useful test deliberately separates a clinically plausible action from an authorised one. Something can sound reasonable yet fall outside the permitted task. Conversely, a technically authorised action may still require clinical challenge.
Review the people and services behind the connection
The model is not the only actor to consider. A deployment may involve a service account, an integration provider, support staff and administrators who can change configuration. Determine whose authority each component uses and whether its activity can be distinguished in an audit.
A proposed review should cover account creation, role changes, staff departure, emergency access and supplier support. It should also identify who can revoke permissions quickly without waiting for the original project lead. Temporary access should not become permanent merely because nobody owns the expiry decision.
The NCSC's secure-development guidance, published in November 2023, treats supply-chain and asset understanding as part of secure AI development. In a local healthcare review, that means examining the connected service, not only the visible chat interface.
Test a narrow workflow before expanding authority
Start with the smallest useful, clinically appropriate scope and evaluate it in an authorised environment. Measure whether the tool completes the intended task, requests additional access appropriately and remains contained when information is incomplete or misleading.
Expansion should be a new decision supported by evidence. A successful drafting pilot does not automatically justify sending, ordering or closing tasks. Nor should an inconvenient approval step be removed without understanding what risk it was controlling.
For staff education, use a fictional scenario in which the assistant knows enough to suggest an action but lacks authority to execute it. Ask the learner to explain both the clinical judgement and the permission boundary. This is a useful discussion topic alongside clinical learning, not a claim that a reference or tutoring platform can audit production access controls.
Frequently asked questions
Is read-only access automatically low risk?
No. Unnecessary reading can expose confidential information and introduce irrelevant context, although it creates different risks from authority to change records or send messages.
Should an AI assistant inherit every permission its user has?
Not automatically. The appropriate grant should reflect the particular task and consequences, while remaining sufficient for the information the task genuinely requires.
Does human approval make broad permissions acceptable?
Approval can be useful, but only when the reviewer can understand the proposed action and the surrounding system enforces the relevant limits. A confirmation button is not a substitute for scoped access.